Financing - June 27, 2014
Xvivo completes private placement of shares
The board of directors of Xvivo Perfusion AB has resolved to issue 1,950,000 new shares in Xvivo through a private placement directed to a group of qualified Swedish and international investors. The subscription price for each new share was set to SEK 37.50 through a book-building procedure. Through the Private Placement Xvivo raises SEK 73,125,000 before issue costs. The […]
In a new job - June 26, 2014
Swedish Medical Products Agency gets new Director General
The Swedish government has appointed Catarina Andersson Forsman as new Director General of the agency. Andersson Forsman has previously worked as deputy county council director and healthcare director for the Stockholm County Council. She has also been executive director of the Swedish Medical Association and as director at the National Board of Health and Welfare. […]
Uncategorized - June 26, 2014
Nordic partnering for global life science
In September, decision makers from the life science sector will meet in the Swedish capital for the second Nordic Life Science Days conference. The event, hosted by the Swedish life science industry organization SwedenBIO, is the largest Nordic partnering conference for the global life science industry and brings together the best talent in life science, […]
Financing - June 26, 2014
Novo Nordisk to double revenue says deputy CEO
Danish drugmaker Novo Nordisk expects to double its annual revenue within the next ten years, according to deputy CEO Kåre Schultz. Novo Nordisk has had a tough year so far as the company failed to post double-digit sales growth in the first quarter for the first time in four years. But the results for 2014 might be a […]
Uncategorized - June 25, 2014
Entrepreneur stories on Life Science Day
June 24 was the first time for Life Science Day during the Entrepreneur Week event in Båstad and several life science companies were there to tell their stories. Among others, Bactiguard CEO Christian Kinch and Scilife Clinic founder Mouna Ezmaelizadeh talked about the journey and life as entrepreneurs. Christoffer Lindhe, founder of medtech company Lindhextend […]
Drug Development Pharma - June 25, 2014
Sobi files for EU approval of Xiapex for Peyronies disease
Sobi has filed for an extension of the label for Xiapex with the European Medicines Agency (EMA) to include the indication of Peyronie’s disease. The filing is based on positive safety and efficacy outcome data from two double-blind placebo-controlled studies, IMPRESS I and II (The Investigation for Maximal Peyronie’s Reduction Efficacy and Safety Studies) which […]
